Keyword: AbbVie

AbbVie inked a deal with the Medicines Patent Pool to boost access to hep C drug Mavyret in nearly 100 low- and middle-income countries and territories.

Pushing to eradicate hepatitis C in England, the NHS is weighing bids for bulk drug buys, but AbbVie has sued over an unfair bidding process.

Less than five months after posting positive top-line data, Bristol-Myers Squibb and AbbVie have scored a new combo win for Empliciti.

Is Pfizer’s Lyrica leaving the TV ad game? Facing patent expiration, the stalwart top 10 TV spender dropped its budget to $3.8 million in October.

Over the first nine months of 2018, the Illinois pharma has paid just 4.5% of the income taxes it shelled out over the same period last year.

AbbVie and Roche aim to drive further into the chronic lymphocytic leukemia market, and they’re pairing their newer drugs to do it.

The enormous discount AbbVie gave to win a contract in the EU shows just how far it'll go to fight off Humira biosimilars.

Nine years after the whistle first blew, Abbott and AbbVie have settled claims that they paid kickbacks to pump up TriCor sales.